BMP4 Thymic Regeneration via Intermediary Signaling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The thymus is highly sensitive to damage from stress, infection, age, and cytoreductive treatments like chemotherapy and radiation, leading to a decline in immune function, and existing strategies have limitations in promoting thymic regeneration and enhancing thymic epithelial cell function.
Innovation Solution
Administering bone morphogenetic protein 4 (BMP4) or thymic endothelial cells that secrete BMP4 to the thymus, either directly or through intravenous or intrathymic routes, to increase thymic cellularity and promote regeneration, particularly by using recombinant BMP4 or transduced endothelial cells expressing the adenoviral gene E4ORF1.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the thymus is exposed to stress, infection, age, or cytoreductive treatments, then immune function is compromised, but the thymus has extensive capacity for regeneration
Solution Approach 1:
The patent introduces BMP4 as an intermediary signaling molecule that mediates the regenerative process. BMP4 acts as a mediator between the injury signal and the regenerative response, activating specific signaling pathways that promote thymic regeneration and restore immune function after damage from stress, infection, age, chemotherapy, or radiation.
Solution Approach 2:
The patent employs preliminary action by administering BMP4 or BMP4-secreting endothelial cells before or at the early stages of thymic damage to prevent severe immunosuppression. This preliminary intervention activates regenerative pathways before the thymus can be completely compromised, thereby maintaining immune function more effectively than waiting for damage to occur.
2Quantity of substance
If BMP4 is administered to promote thymic regeneration, then thymic cellularity increases, but the complexity of treatment increases
Solution Approach 1:
The patent uses BMP4 as a soluble intermediary factor that can be administered in a simplified manner compared to direct cell transplantation. BMP4 serves as a mediator that triggers endogenous regenerative processes, eliminating the need for complex ex vivo cell manipulation and reducing treatment complexity while still achieving increased thymic cellularity.
Solution Approach 2:
The patent employs a simplified approach by using recombinant BMP4 protein or viral vectors to deliver BMP4 signaling, rather than requiring complex ex vivo expansion and manipulation of endothelial cells. This copying approach uses the essential regenerative signal (BMP4) without the complexity of whole-cell therapy, thereby increasing thymic cellularity with reduced treatment complexity.
3Reliability
If thymic endothelial cells are used to secrete BMP4, then thymic epithelial cell function is enhanced, but the difficulty of cell manipulation increases
Solution Approach 1:
The patent uses viral vectors as intermediaries to deliver BMP4-secreting capabilities to endothelial cells. The viral vector acts as a mediator that transfers the genetic information for BMP4 secretion into the endothelial cells, simplifying the manipulation process compared to direct genetic modification methods while still achieving enhanced thymic epithelial cell function through BMP4 secretion.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances thymic regeneration by increasing the number of mature functional T-cells, promoting thymic epithelial cell function, and aiding in the recovery of thymic cellularity after damage, as demonstrated by increased BMP4 expression and FOXN1 upregulation in thymic epithelial cells.
Implementation Method 1
contacting the thymus with bone morphogenetic protein 4 (BMP4) in an amount sufficient to increase thymic cellularity and/or promote regeneration of the injured thymus
Data Source
AI summary
The present disclosure describes methods to promote thymic regeneration following injury or damage to the thymus by administering to the thymus an effective amount of (1) bone morphogenetic protein 4 (BMP4), (2) thymus-derived endothelial cells that express BMP4 or (3) a combination of BMP4 and BMP4-secreting thymus-derived endothelial cells.